Emily P. McCann

Identity-by-descent to resolve reduced penetrance and advance gene discovery in neurodegenerative disease.

Advances in sequencing technologies have transformed human genetics and accelerated disease gene discovery. Yet a causal mutation remains to be identified for many families with an inherited disease. Incomplete penetrance, genetic heterogeneity, and limited family history can complicate the binary classification of fam...